FDA

Improving Federal Regulation of Medical Algorithms

Scholar argues that FDA should reform its regulation of algorithm-based medicine.

How to Regulate During a Financial Crisis

Scholar argues that financial regulators must be decisive yet agile when using imperfect information.

Regulating the Antibiotic Resistance Crisis

Scholar praises a California law that widely eliminates antibiotics use in the livestock industry.

Doctors or Devices?

Scholar weighs the possibility of regulating medical artificial intelligence like human professionals.

Allowing Students to Access Sunscreen Without Restriction

Legislatures reconsider whether students can access sunscreen in school without a doctor’s note.

For Smokers Trying to Quit, Information Could Be Key

Scholar argues that recent FDA regulations may keep smokers in the dark about e-cigarettes.

How FDA Should Use Its Authority to Regulate Human Cells

FDA should encourage states to be the primary regulators of stem cell procedures.

FDA’s Authority to Regulate Off-Label Promotion

Expert argues that federal law gives regulator authority to restrict unauthorized drug uses.

Bolstering Supplement Regulations

Lawyer argues that United States should ramp up regulation of dietary supplements.

Should We Run Agencies More Like Businesses?

Legal scholar argues for greater reliance on entrepreneurial strategies in regulation.

Learning from International Agreements and Domestic Missteps

Scholar argues U.S.-China trade agreements fill regulatory gaps left by both countries.

Giving the Platypus of Formal Rulemaking a Second Look, Again

Legal scholar reexamines the formal rulemaking process in response to criticism.